HOME >> MEDICINE >> NEWS
Emselex(R) receives positive CHMP opinion for the treatment of overactive bladder

Basel, 30th July 2004 Novartis Pharma AG announced today that the Committee for Medicinal Products for Human Use (CHMP), adopted a positive opinion recommending that the European Commission (EC) grant a Marketing Authorisation for Emselex (darifenacin hydrobromide), 7.5mg and 15mg, for the treatment of overactive bladder (OAB) in all 25 European Union (EU) countries as well as Norway and Iceland. Upon receipt of the EC approval, Novartis will be able to market Emselex throughout these countries.

"We are delighted by the CHMP's positive opinion for Emselex, to provide overactive bladder sufferers with a new safe and effective treatment option", said Jrg Reinhardt, Global Head of Development Novartis Pharma AG. "Due to its M3 selectivity, Emselex provides effective overactive bladder symptom relief while decreasing the potential risk of safety issues such as cognitive impairment or effects on cardiac function."

OAB affects almost one in six adults in Europe1. Symptoms of overactive bladder are urinary urgency (a sudden compelling desire to pass urine, which is difficult to defer) with or without urge incontinence (involuntary leakage accompanied by urgency), urinary frequency (voiding the bladder too often), and nocturia (waking at night one or more times to void the bladder).

The CHMP based its positive opinion on Emselex's comprehensive data package for OAB. The safety and efficacy of Emselex has been extensively studied in over 90 pre-clinical studies and clinical trials, involving more than 5,000 patients. Pivotal studies explored key endpoints including the reduction in the number of incontinence episodes per week, the reduction in the number of voluntary urination episodes (micturition) per day, the reduction in the episodes and severity of urgency and an increase in the average volume of urine passed per micturition.

The phase III clinical
'"/>


30-Jul-2004


Page: 1 2 3

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
(Date:7/23/2014)... By 2013, there were about ... equipment in China, including about 320 related enterprises ... and remaining more than 200 enterprises mainly engaging ... end of 2013, the total output value of ... billion, accounting for 55.94% of the dust-collecting equipment’s ...
(Date:7/23/2014)... “Unlike most Sales Training Programs, the Sales ... unique gifts, talents and abilities as opposed to giving ... Ja Marr Brown. It is based on ... transformation from nearly getting fired for poor sales performance ... sales contest offered and taking a last placed sales ...
(Date:7/23/2014)... The age spots, wrinkles and puffy eyes that can ... are now explored in a new guide posted at the ... women over 30 are introduced in the guide as well ... use of creams as an alternative to surgery is one ... to the information in the new guide. Because there are ...
(Date:7/23/2014)... adults living near Sellafield or Dounreay since the 1990s ... according to research published in the British Journal ... Childhood Cancer Research Group at the University of Oxford ... and 2006 among those who were under 25 and ... was found in cancer incidence from 1991-2006 between those ...
(Date:7/23/2014)... from the University of Exeter has developed a ... a frequently fatal lung disease which attacks immune ... marrow transplant recipients. , The lateral-flow device (LFD), ... aspergillosis, a notoriously difficult to diagnose disease caused ... , Invasive aspergillosis is a leading cause ...
Breaking Medicine News(10 mins):Health News:2018 Dust Collecting Equipment Industry in China Major Enterprises Analysis Now Available at MarketReportsChina.com 2Health News:2018 Dust Collecting Equipment Industry in China Major Enterprises Analysis Now Available at MarketReportsChina.com 3Health News:Using Your Story and Not Technique to Achieve Sales Success 2Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2Health News:New device detects deadly lung disease 2
(Date:7/23/2014)... CHICAGO, Ill. , July 23, 2014 ... OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ... OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. ... second-quarter 2014 financial results on Friday, July 25, 2014, before ... webcast of the earnings conference call at 8 a.m. Central ...
(Date:7/23/2014)... 2014 Research and Markets   ... Electrophysiology Ablation Catheters Market 2014-2018" report to ... Catheter ablation is a minimally ... electrical pathways from sections of the heart that ... arrhythmias). Cardiac arrhythmias can be of several types, ...
(Date:7/23/2014)... , July 23, 2014  Nonin Medical, Inc., the ... noninvasive medical monitoring, announced today that Mark VanderWerf ... been elected Chairman of the American Telemedicine Association,s (ATA) ... Directors. The ATA is the leading international ... medical technologies. The ATA and its diverse membership work ...
Breaking Medicine Technology:AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Nonin Medical Announces that Mark VanderWerf has been Elected Chairman of the American Telemedicine Association's Industry Council 2
Cached News: